BACKGROUND: Altered expression of synaptic plasticity within the nucleus accumbens (NAc) constitutes a critical neuroadaptive response to ethanol (EtOH) and other drugs of abuse. We have previously reported that N-methyl-D-aspartate receptor (NMDAR)-dependent long-term depression (LTD) is markedly affected by chronic intermittent ethanol exposure in vivo; however, endocannabinoid (eCB)-dependent synaptic depression, despite being very well-documented in the dorsal striatum, is much less well understood in the NAc. METHODS: Whole cell patch clamp electrophysiology was used to investigate interactions between these different plasticity-induction systems. Excitatory postsynaptic currents (EPSCs) were measured in the NAc shell and NMDAR-LTD was induced by a pairing protocol (500 stimuli at 1 Hz stimulation [low-frequency stimulation (LFS)] paired with postsynaptic depolarization to -50 mV). AM251, a CB1 receptor antagonist, was used to determine whether this form of LTD is modulated by eCBs. To determine the effect of EtOH on a purely eCB-dependent response in the NAc, depolarization-induced suppression of excitation (DSE) was used in the presence of 40 mM EtOH. Finally, we determined whether the enhancement of eCB signaling with URB597, a fatty acid amide hydrolase inhibitor, and AM404, an anandamide re-uptake inhibitor would also modulate LFS LTD in the presence of NMDAR blockade or EtOH. RESULTS: In the presence of AM251, the LFS pairing protocol resulted in NMDAR-dependent long-term potentiation that was blocked with either EtOH or DL-APV. We also found that DSE in the NAc shell was blocked by AM251 and suppressed by EtOH. Enhanced eCB signaling rescued NAc-LTD expression in the presence of EtOH through a distinct mechanism requiring activation of TRPV1 receptors. CONCLUSIONS: EtOH modulation of synaptic plasticity in the NAc is dependent upon a complex interplay between NMDARs, eCBs, and TRPV1 receptors. These findings demonstrate a novel form of TRPV1-dependent LTD in the NAc shell that may be critical for EtOH dependence.
BACKGROUND: Altered expression of synaptic plasticity within the nucleus accumbens (NAc) constitutes a critical neuroadaptive response to ethanol (EtOH) and other drugs of abuse. We have previously reported that N-methyl-D-aspartate receptor (NMDAR)-dependent long-term depression (LTD) is markedly affected by chronic intermittent ethanol exposure in vivo; however, endocannabinoid (eCB)-dependent synaptic depression, despite being very well-documented in the dorsal striatum, is much less well understood in the NAc. METHODS: Whole cell patch clamp electrophysiology was used to investigate interactions between these different plasticity-induction systems. Excitatory postsynaptic currents (EPSCs) were measured in the NAc shell and NMDAR-LTD was induced by a pairing protocol (500 stimuli at 1 Hz stimulation [low-frequency stimulation (LFS)] paired with postsynaptic depolarization to -50 mV). AM251, a CB1 receptor antagonist, was used to determine whether this form of LTD is modulated by eCBs. To determine the effect of EtOH on a purely eCB-dependent response in the NAc, depolarization-induced suppression of excitation (DSE) was used in the presence of 40 mM EtOH. Finally, we determined whether the enhancement of eCB signaling with URB597, a fatty acid amide hydrolase inhibitor, and AM404, an anandamide re-uptake inhibitor would also modulate LFS LTD in the presence of NMDAR blockade or EtOH. RESULTS: In the presence of AM251, the LFS pairing protocol resulted in NMDAR-dependent long-term potentiation that was blocked with either EtOH or DL-APV. We also found that DSE in the NAc shell was blocked by AM251 and suppressed by EtOH. Enhanced eCB signaling rescued NAc-LTD expression in the presence of EtOH through a distinct mechanism requiring activation of TRPV1 receptors. CONCLUSIONS:EtOH modulation of synaptic plasticity in the NAc is dependent upon a complex interplay between NMDARs, eCBs, and TRPV1 receptors. These findings demonstrate a novel form of TRPV1-dependent LTD in the NAc shell that may be critical for EtOH dependence.
Authors: Belen Ferrer; Francisco Javier Bermúdez-Silva; Ainhoa Bilbao; Lily Alvarez-Jaimes; Irene Sanchez-Vera; Andrea Giuffrida; Antonia Serrano; Elena Baixeras; Satishe Khaturia; Miguel Navarro; Loren H Parsons; Daniele Piomelli; Fernando Rodríguez de Fonseca Journal: Biochem J Date: 2007-05-15 Impact factor: 3.857
Authors: Karen Brebner; Tak Pan Wong; Lidong Liu; Yitao Liu; Paul Campsall; Sarah Gray; Lindsay Phelps; Anthony G Phillips; Yu Tian Wang Journal: Science Date: 2005-11-25 Impact factor: 47.728
Authors: Marina Rubio; Douglas McHugh; Javier Fernández-Ruiz; Heather Bradshaw; J Michael Walker Journal: Neurosci Lett Date: 2007-06-02 Impact factor: 3.046
Authors: David Robbe; Manfred Kopf; Anne Remaury; Joel Bockaert; Olivier J Manzoni Journal: Proc Natl Acad Sci U S A Date: 2002-06-11 Impact factor: 11.205
Authors: Max E Joffe; Samuel W Centanni; Anel A Jaramillo; Danny G Winder; P Jeffrey Conn Journal: ACS Chem Neurosci Date: 2018-06-08 Impact factor: 4.418
Authors: Brian R Christie; Pedro Grandes; Sara Peñasco; Irantzu Rico-Barrio; Nagore Puente; Christine J Fontaine; Almudena Ramos; Leire Reguero; Inmaculada Gerrikagoitia; Fernando Rodríguez de Fonseca; Juan Suarez; Sergio Barrondo; Xabier Aretxabala; Gontzal García Del Caño; Joan Sallés; Izaskun Elezgarai; Patrick C Nahirney Journal: Neuropsychopharmacology Date: 2019-09-30 Impact factor: 7.853
Authors: R Renteria; Z M Jeanes; R A Mangieri; E Y Maier; D M Kircher; T R Buske; R A Morrisett Journal: Int Rev Neurobiol Date: 2016-03-24 Impact factor: 3.230
Authors: Brandon D Turner; Daniel T Kashima; Kevin M Manz; Carrie A Grueter; Brad A Grueter Journal: ACS Chem Neurosci Date: 2018-01-24 Impact factor: 4.418
Authors: Daniela Neuhofer; Sade M Spencer; Vivian C Chioma; Lauren N Beloate; Danielle Schwartz; Peter W Kalivas Journal: Addict Biol Date: 2019-11-16 Impact factor: 4.280